Aminoquinoline derivatives and their use as adenosine A3...

Details Aminoquinoline derivatives and their use as adenosine A3... Aminoquinoline derivatives and their use as adenosine A3...

2006-01-31

2009-06-16

Anderson, Rebecca L (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S128000

Reexamination Certificate

active

07547696

ABSTRACT:
The present invention relates to an adenosine A3receptor ligand of the general formula (I), within those preferably to the antagonists, including a salt, solvate or isomer (tautomer, desmotrop, and optically active isomer) thereof, to a pharmaceutical composition containing the ligand, to the use of the ligand, to its preparation, and intermediates of the ligand of the general formula (II″), (III″), (IV″), (V″), (VI″), (VII″), (VIII″) and (XIII″) and their preparation.

REFERENCES:
patent: 6969723 (2005-11-01), Aranyi et al.
patent: 0566226 (1993-10-01), None
patent: 1180514 (2002-02-01), None
patent: WO98/43960 (1998-10-01), None
patent: WO 02/096879 (2002-12-01), None
Science (1999), vol. 286, 531-537.
Rimmer et al., Clinical and Experimental Allergy, 37, 8-14 (2007).
Kreckler et al., The Journal of Pharmacology and Experimental Therapeutics, vol. 317, No. 1, pp. 172-180 (2006).
Gessi et al., Pharmacology & Therapeutics 117(2008) 123-140.
Nakamura et al., Anticancer Res. 2006; 26(1A);43-47, abstract only.
Burduliene, et al., Chloroethyl derivatives of 2,5-diaminobenzoic acid, Database Beilstein, Beilstein Institute for Organic Chemistry, XP002299337, vol. 4, (1973) pp. 55-58.
Carboni, S., Researches in the field of pyridine. I. 2-Amino-5-nitronicotinic acid, Database Beilstein, Beilstein Institute for Organic Chemistry, XP002299336, Abstract vol. 83, (1953), pp. 637-640.
Hynes, J.B., et al., Improved Synthesis and Antitumor Evaluation of 5,8-Dideazaisofolic Acid and Closely Related Analogues, J. Med. Chem. 1984, 27, 232-235.
Jakobsen, et al., Inhibitors of the Tissue Factor/Factor VIIa-Induced Coagulation: Synthesis and In Vitro Evaluation of Novel Specific 2-Aryl Substituted 4H-3,1-Benzoxazin-4-ones, Bioorganic & Medicinal Chemistry 8 (2000) 2095-2103.
Chou et al., Beilstein Abstract No. 9271163.
Chou et al., Structure-Activity Relationships of Substituted Benzothiopheneanthranilamide Factor Xa Inhibitors, Bioorg. Med. Chem. Lett. 13(2003), pp. 507-511.

Affiliated with

Also associated with

Rating

Aminoquinoline derivatives and their use as adenosine A3... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aminoquinoline derivatives and their use as adenosine A3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoquinoline derivatives and their use as adenosine A3... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4128869